Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS (2002. április 1.). „Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells”. Genes & Development16 (8), 948–958. o. DOI:10.1101/gad.981002. PMID11959843. PMC152352.
Brummelkamp TR, Bernards R, Agami R (2002. április 1.). „A system for stable expression of short interfering RNAs in mammalian cells”. Science296 (5567), 550–553. o. DOI:10.1126/science.1068999. PMID11910072.
Wang Z, Rao DD, Senzer N, Nemunaitis J (2011. december 1.). „RNA interference and cancer therapy”. Pharmaceutical Research28 (12), 2983–2995. o. DOI:10.1007/s11095-011-0604-5. PMID22009588.
Burnett JC, Rossi JJ, Tiemann K (2011. szeptember 1.). „Current progress of siRNA/shRNA therapeutics in clinical trials”. Biotechnology Journal6 (9), 1130–46. o. DOI:10.1002/biot.201100054. PMID21744502. PMC3388104.
Macrae IJ, Zhou K, Li F, Repic A, Brooks AN, Cande WZ, Adams PD, Doudna JA (2006. január 1.). „Structural basis for double-stranded RNA processing by Dicer”. Science311 (5758), 195–198. o. DOI:10.1126/science.1121638. PMID16410517.
Senzer N, Barve M, Kuhn J, Melnyk A, Beitsch P, Lazar M, Lifshitz S, Magee M, Oh J, Mill SW, Bedell C, Higgs C, Kumar P, Yu Y, Norvell F, Phalon C, Taquet N, Rao DD, Wang Z, Jay CM, Pappen BO, Wallraven G, Brunicardi FC, Shanahan DM, Maples PB, Nemunaitis J (2012. március 1.). „Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer”. Molecular Therapy20 (3), 679–686. o. DOI:10.1038/mt.2011.269. PMID22186789. PMC3293620.
Persons DA, Baum C (2011. február 1.). „Solving the problem of γ-retroviral vectors containing long terminal repeats”. Molecular Therapy19 (2), 229–231. o. DOI:10.1038/mt.2010.305. PMID21289636. PMC3034864.
Whitehead KA, Dahlman JE, Langer RS, Anderson DG (2011). „Silencing or stimulation? siRNA delivery and the immune system”. Annual Review of Chemical and Biomolecular Engineering2, 77–96. o. DOI:10.1146/annurev-chembioeng-061010-114133. PMID22432611.
Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS (2002. április 1.). „Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells”. Genes & Development16 (8), 948–958. o. DOI:10.1101/gad.981002. PMID11959843. PMC152352.
Brummelkamp TR, Bernards R, Agami R (2002. április 1.). „A system for stable expression of short interfering RNAs in mammalian cells”. Science296 (5567), 550–553. o. DOI:10.1126/science.1068999. PMID11910072.
Wang Z, Rao DD, Senzer N, Nemunaitis J (2011. december 1.). „RNA interference and cancer therapy”. Pharmaceutical Research28 (12), 2983–2995. o. DOI:10.1007/s11095-011-0604-5. PMID22009588.
Burnett JC, Rossi JJ, Tiemann K (2011. szeptember 1.). „Current progress of siRNA/shRNA therapeutics in clinical trials”. Biotechnology Journal6 (9), 1130–46. o. DOI:10.1002/biot.201100054. PMID21744502. PMC3388104.
Macrae IJ, Zhou K, Li F, Repic A, Brooks AN, Cande WZ, Adams PD, Doudna JA (2006. január 1.). „Structural basis for double-stranded RNA processing by Dicer”. Science311 (5758), 195–198. o. DOI:10.1126/science.1121638. PMID16410517.
Senzer N, Barve M, Kuhn J, Melnyk A, Beitsch P, Lazar M, Lifshitz S, Magee M, Oh J, Mill SW, Bedell C, Higgs C, Kumar P, Yu Y, Norvell F, Phalon C, Taquet N, Rao DD, Wang Z, Jay CM, Pappen BO, Wallraven G, Brunicardi FC, Shanahan DM, Maples PB, Nemunaitis J (2012. március 1.). „Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer”. Molecular Therapy20 (3), 679–686. o. DOI:10.1038/mt.2011.269. PMID22186789. PMC3293620.
Persons DA, Baum C (2011. február 1.). „Solving the problem of γ-retroviral vectors containing long terminal repeats”. Molecular Therapy19 (2), 229–231. o. DOI:10.1038/mt.2010.305. PMID21289636. PMC3034864.
Whitehead KA, Dahlman JE, Langer RS, Anderson DG (2011). „Silencing or stimulation? siRNA delivery and the immune system”. Annual Review of Chemical and Biomolecular Engineering2, 77–96. o. DOI:10.1146/annurev-chembioeng-061010-114133. PMID22432611.
ncbi.nlm.nih.gov
Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS (2002. április 1.). „Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells”. Genes & Development16 (8), 948–958. o. DOI:10.1101/gad.981002. PMID11959843. PMC152352.
Burnett JC, Rossi JJ, Tiemann K (2011. szeptember 1.). „Current progress of siRNA/shRNA therapeutics in clinical trials”. Biotechnology Journal6 (9), 1130–46. o. DOI:10.1002/biot.201100054. PMID21744502. PMC3388104.
Senzer N, Barve M, Kuhn J, Melnyk A, Beitsch P, Lazar M, Lifshitz S, Magee M, Oh J, Mill SW, Bedell C, Higgs C, Kumar P, Yu Y, Norvell F, Phalon C, Taquet N, Rao DD, Wang Z, Jay CM, Pappen BO, Wallraven G, Brunicardi FC, Shanahan DM, Maples PB, Nemunaitis J (2012. március 1.). „Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer”. Molecular Therapy20 (3), 679–686. o. DOI:10.1038/mt.2011.269. PMID22186789. PMC3293620.
Persons DA, Baum C (2011. február 1.). „Solving the problem of γ-retroviral vectors containing long terminal repeats”. Molecular Therapy19 (2), 229–231. o. DOI:10.1038/mt.2010.305. PMID21289636. PMC3034864.